Mosaic ImmunoEngineering CPMV
OTC CPMV
$0.06 +0.00 (+0.00%)
As of: Oct 21, 2026 · 11:47 AM EDT

Mosaic ImmunoEngineering (CPMV) Receivables - Net (2011)

Updated

Mosaic ImmunoEngineering's Receivables - Net came in at $113,786 for Q2 2012, up 314.4% from the prior quarter.

Analysis

Mosaic ImmunoEngineering (CPMV) Receivables - Net (2011) Analysis & Trends

At the end of FY2011, Mosaic ImmunoEngineering's Receivables - Net was $187,465.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,133.19 Bn 1,101.77 Bn 19.71 Bn
2 Johnson & Johnson 616.03 Bn 534.56 Bn 17.26 Bn
3 AbbVie 501.09 Bn 474.20 Bn 12.70 Bn
4 Merck 366.82 Bn 321.20 Bn 12.21 Bn
5 Novartis Ag 297.82 Bn 261.81 Bn 11.24 Bn
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn
7 Amgen 235.89 Bn 191.29 Bn 7.24 Bn
8 Gilead Sciences 190.64 Bn 164.84 Bn 6.22 Bn
9 Pfizer 169.32 Bn 115.96 Bn 10.94 Bn
10 Mosaic ImmunoEngineering 441,423.27 352,385.27 -
Historic Data

Historic Data

Download Data
DateValue
Nov 30, 2011 113,786.00
Aug 31, 2011 27,456.00
May 31, 2011 187,465.00
API Access

Mosaic ImmunoEngineering Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=CPMV&period=max&api_key=YOUR_API_KEY